| Insideraktier | 34 952 635 shares |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Nettoantalet insiders som köper (rankning)
N/A
Nettoantalet insiders som köper är den totala mängden insiders som säljer minus det totala antalet insiders som säljer under de senaste 90 dagarna. Percentilrankningen visas här (intervall från 0 till 100%).
Procent av flytande köpta av insiders (ranking)
N/A
Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Humanigen, Inc. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i HGEN / Humanigen, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i HGEN / Humanigen, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-20 | 2023-10-18 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 0,0110 | −276 210 | −3 | 8 398 871 | ||||
| 2023-10-20 | 2023-10-18 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 0,0110 | −75 887 | −1 | 2 307 530 | ||||
| 2023-10-20 | 2023-10-18 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 0,0110 | −34 253 | −0 | 1 041 536 | ||||
| 2022-05-20 | 2022-05-20 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 2,2280 | 381 841 | 851 | 8 675 081 | ||||
| 2022-05-20 | 2022-05-20 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 2,2280 | 109 098 | 243 | 2 383 417 | ||||
| 2022-05-20 | 2022-05-20 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 2,2280 | 54 549 | 122 | 1 075 789 | ||||
| 2022-05-20 | 2022-05-19 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 2,1860 | 226 665 | 495 | 8 293 240 | ||||
| 2022-05-20 | 2022-05-19 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 2,1860 | 64 762 | 142 | 2 274 319 | ||||
| 2022-05-20 | 2022-05-19 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 2,1860 | 32 381 | 71 | 1 021 240 | ||||
| 2022-05-20 | 2022-05-18 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 1,9620 | 121 590 | 239 | 8 066 575 | ||||
| 2022-05-20 | 2022-05-18 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 1,9620 | 34 740 | 68 | 2 209 557 | ||||
| 2022-05-20 | 2022-05-18 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 1,9620 | 17 370 | 34 | 988 859 | ||||
| 2022-03-15 | 2022-03-11 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 3,0000 | 700 000 | 2 100 | 7 944 985 | ||||
| 2022-03-15 | 2022-03-11 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 3,0000 | 200 000 | 600 | 2 174 817 | ||||
| 2022-03-15 | 2022-03-11 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 3,0000 | 100 000 | 300 | 971 489 | ||||
| 2022-03-14 | 2022-03-09 | 4 | Kilcoyne Adrian | HGEN | Common Stock | D | 2,7800 | 5 000 | 14 | 12 000 | ||||
| 2022-03-14 | 2022-03-08 | 4 | Kilcoyne Adrian | HGEN | Common Stock | D | 2,5300 | 7 000 | 18 | 7 000 | ||||
| 2022-03-10 | 2022-03-10 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,7500 | 550 | 0 | 2 866 | |||
| 2022-03-10 | 2022-03-10 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,7500 | 157 | 0 | 818 | |||
| 2022-03-10 | 2022-03-10 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,7500 | 79 | 0 | 410 | |||
| 2022-03-10 | 2022-03-09 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,7870 | 1 026 | 1 | 2 316 | |||
| 2022-03-10 | 2022-03-09 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 1,2000 | 36 | 0 | 7 393 | |||
| 2022-03-10 | 2022-03-09 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,7870 | 293 | 0 | 661 | |||
| 2022-03-10 | 2022-03-09 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 1,2000 | 10 | 0 | 2 111 | |||
| 2022-03-10 | 2022-03-09 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,7870 | 147 | 0 | 331 | |||
| 2022-03-10 | 2022-03-09 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 2,50 | 1,2000 | 5 | 0 | 1 055 | |||
| 2022-03-10 | 2022-03-08 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 1,2000 | 1 668 | 2 | 7 357 | |||
| 2022-03-10 | 2022-03-08 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 1,2000 | 476 | 1 | 2 101 | |||
| 2022-03-10 | 2022-03-08 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 2,50 | 1,2000 | 238 | 0 | 1 050 | |||
| 2022-03-04 | 2022-03-04 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,8972 | 891 | 1 | 5 689 | |||
| 2022-03-04 | 2022-03-04 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,8972 | 255 | 0 | 1 625 | |||
| 2022-03-04 | 2022-03-04 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,8972 | 127 | 0 | 812 | |||
| 2022-03-04 | 2022-03-03 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,3500 | 1 213 | 0 | 1 290 | |||
| 2022-03-04 | 2022-03-03 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,7000 | 36 | 0 | 4 798 | |||
| 2022-03-04 | 2022-03-03 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,3500 | 346 | 0 | 368 | |||
| 2022-03-04 | 2022-03-03 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,7000 | 10 | 0 | 1 370 | |||
| 2022-03-04 | 2022-03-03 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,3500 | 173 | 0 | 184 | |||
| 2022-03-04 | 2022-03-03 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,7000 | 5 | 0 | 685 | |||
| 2022-03-04 | 2022-03-02 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,3255 | 77 | 0 | 77 | |||
| 2022-03-04 | 2022-03-02 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,5960 | 4 762 | 3 | 4 762 | |||
| 2022-03-04 | 2022-03-02 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,3255 | 22 | 0 | 22 | |||
| 2022-03-04 | 2022-03-02 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,5960 | 1 360 | 1 | 1 360 | |||
| 2022-03-04 | 2022-03-02 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 5,00 | 0,3255 | 11 | 0 | 11 | |||
| 2022-03-04 | 2022-03-02 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Call Option (Right to Buy) | I | 2,50 | 0,5960 | 680 | 0 | 680 | |||
| 2022-03-04 | 2022-03-02 | 4 | Durrant Cameron By Cameron Durrant Revocable Trust | HGEN | Common Stock | I | 2,3400 | 40 000 | 94 | 70 000 | ||||
| 2022-03-04 | 2022-03-02 | 4 | Jordan Edward P. | HGEN | Common Stock | D | 2,3200 | 12 500 | 29 | 12 500 | ||||
| 2022-01-14 | 2022-01-12 | 4 | MORRIS TIMOTHY E | HGEN | Stock Option (Right to Buy) | D | 2,99 | 59 841 | 59 841 | |||||
| 2022-01-14 | 2022-01-12 | 4 | Kilcoyne Adrian | HGEN | Stock Option (Right to Buy) | D | 2,99 | 38 411 | 38 411 | |||||
| 2022-01-14 | 2022-01-12 | 4 | Chappell Dale | HGEN | Stock Option (Right to Buy) | D | 2,99 | 36 550 | 36 550 | |||||
| 2022-01-14 | 2022-01-12 | 4 | Jordan Edward P. | HGEN | Stock Option (Right to Buy) | D | 2,99 | 43 763 | 43 763 | |||||
| 2022-01-14 | 2022-01-12 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 2,99 | 84 385 | 84 385 | |||||
| 2022-01-04 | 2021-12-31 | 4 | Kilcoyne Adrian | HGEN | Stock Option (Right to Buy) | D | 3,72 | 34 500 | 34 500 | |||||
| 2022-01-04 | 2021-12-31 | 4 | BARLIANT RONALD | HGEN | Stock Option (Right to Buy) | D | 3,72 | 2,8400 | 4 163 | 12 | 4 163 | |||
| 2022-01-04 | 2021-12-31 | 4 | Chappell Dale | HGEN | Stock Option (Right to Buy) | D | 3,72 | 44 600 | 44 600 | |||||
| 2022-01-04 | 2021-12-31 | 4 | Buxton Cheryl | HGEN | Stock Option (Right to Buy) | D | 3,72 | 2,8400 | 5 523 | 16 | 5 523 | |||
| 2022-01-04 | 2021-12-31 | 4 | Boehm Rainer J. | HGEN | Stock Option (Right to Buy) | D | 3,72 | 2,8400 | 5 117 | 15 | 5 117 | |||
| 2022-01-04 | 2021-12-31 | 4 | Jordan Edward P. | HGEN | Stock Option (Right to Buy) | D | 3,72 | 29 400 | 29 400 | |||||
| 2022-01-04 | 2021-12-31 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 3,72 | 76 000 | 76 000 | |||||
| 2022-01-04 | 2021-12-31 | 4 | MORRIS TIMOTHY E | HGEN | Stock Option (Right to Buy) | D | 3,72 | 51 000 | 51 000 | |||||
| 2022-01-04 | 2021-12-31 | 4 | Hohneker John | HGEN | Stock Option (Right to Buy) | D | 3,72 | 2,8400 | 3 538 | 10 | 3 538 | |||
| 2022-01-04 | 2021-12-31 | 4 | Xie Yili Kevin | HGEN | Stock Option (Right to Buy) | D | 3,72 | 2,8400 | 4 674 | 13 | 4 674 | |||
| 2021-11-26 | 2021-11-23 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 5,93 | 4,5300 | −17 660 | −80 | 0 | |||
| 2021-11-26 | 2021-11-23 | 4 | Kilcoyne Adrian | HGEN | Stock Option (Right to Buy) | D | 5,93 | 4,5300 | −5 863 | −27 | 0 | |||
| 2021-11-26 | 2021-11-23 | 4 | Jordan Edward P. | HGEN | Stock Option (Right to Buy) | D | 5,93 | 4,5300 | −4 966 | −22 | 0 | |||
| 2021-10-20 | 2021-10-19 | 4 | Xie Yili Kevin | HGEN | Stock Option (Right to Buy) | D | 6,56 | 42 866 | 42 866 | |||||
| 2021-10-20 | 2021-10-19 | 4 | Hohneker John | HGEN | Stock Option (Right to Buy) | D | 6,56 | 42 866 | 42 866 | |||||
| 2021-10-04 | 2021-09-30 | 4 | Jordan Edward P. | HGEN | Stock Option (Right to Buy) | D | 5,93 | 4 966 | 4 966 | |||||
| 2021-10-04 | 2021-09-30 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 5,93 | 17 660 | 17 660 | |||||
| 2021-10-04 | 2021-09-30 | 4 | Chappell Dale | HGEN | Stock Option (Right to Buy) | D | 5,93 | 22 626 | 22 626 | |||||
| 2021-10-04 | 2021-09-30 | 4 | Kilcoyne Adrian | HGEN | Stock Option (Right to Buy) | D | 5,93 | 5 863 | 5 863 | |||||
| 2021-08-27 | 2020-10-16 | 5 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 20,00 | −80 | 6 532 433 | |||||
| 2021-08-27 | 2020-10-13 | 5 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 20,00 | 0,0938 | −80 | −0 | 6 532 433 | |||
| 2021-08-13 | 2021-08-12 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,1598 | −41 725 | −716 | 7 266 296 | ||||
| 2021-08-13 | 2021-08-12 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,1598 | −11 510 | −198 | 1 980 696 | ||||
| 2021-08-13 | 2021-08-12 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,1598 | −4 316 | −74 | 873 693 | ||||
| 2021-08-13 | 2021-08-11 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0743 | −79 494 | −1 357 | 7 308 021 | ||||
| 2021-08-13 | 2021-08-11 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0743 | −21 929 | −374 | 1 992 206 | ||||
| 2021-08-13 | 2021-08-11 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,0743 | −8 224 | −140 | 878 009 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0342 | −21 311 | −363 | 7 366 204 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0342 | −5 879 | −100 | 2 008 256 | ||||
| 2021-07-30 | 2021-07-29 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,0342 | −2 204 | −38 | 884 029 | ||||
| 2021-07-30 | 2021-07-28 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0411 | −7 027 | −120 | 7 387 515 | ||||
| 2021-07-30 | 2021-07-28 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0411 | −1 938 | −33 | 2 014 135 | ||||
| 2021-07-30 | 2021-07-28 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,0411 | −727 | −12 | 886 233 | ||||
| 2021-07-23 | 2021-07-23 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0406 | −4 048 | −69 | 7 394 542 | ||||
| 2021-07-23 | 2021-07-23 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0406 | −1 117 | −19 | 2 016 073 | ||||
| 2021-07-23 | 2021-07-23 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,0406 | −419 | −7 | 886 960 | ||||
| 2021-07-23 | 2021-07-22 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0377 | −129 054 | −2 199 | 7 398 590 | ||||
| 2021-07-23 | 2021-07-22 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0377 | −35 601 | −607 | 2 017 190 | ||||
| 2021-07-23 | 2021-07-22 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,0377 | −13 350 | −227 | 887 379 | ||||
| 2021-07-23 | 2021-07-21 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,1366 | −96 254 | −1 649 | 7 527 644 | ||||
| 2021-07-23 | 2021-07-21 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,1366 | −26 553 | −455 | 2 052 791 | ||||
| 2021-07-23 | 2021-07-21 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,1366 | −9 957 | −171 | 900 729 | ||||
| 2021-07-16 | 2021-07-14 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0552 | −11 003 | −188 | 7 623 898 | ||||
| 2021-07-16 | 2021-07-14 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0552 | −3 036 | −52 | 2 079 344 | ||||
| 2021-07-16 | 2021-07-14 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,0552 | −1 138 | −19 | 910 686 | ||||
| 2021-07-09 | 2021-07-09 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,3721 | −214 626 | −3 729 | 7 634 901 | ||||
| 2021-07-09 | 2021-07-09 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,3721 | −59 207 | −1 029 | 2 082 380 | ||||
| 2021-07-09 | 2021-07-09 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,3721 | −22 203 | −386 | 911 824 | ||||
| 2021-07-09 | 2021-07-08 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,1654 | −34 807 | −597 | 7 849 527 | ||||
| 2021-07-09 | 2021-07-08 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,1654 | −9 602 | −165 | 2 141 587 | ||||
| 2021-07-09 | 2021-07-08 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,1654 | −3 601 | −62 | 934 027 | ||||
| 2021-07-02 | 2021-07-02 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,1200 | −74 565 | −1 277 | 7 884 334 | ||||
| 2021-07-02 | 2021-07-02 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,1200 | −20 569 | −352 | 2 151 189 | ||||
| 2021-07-02 | 2021-07-02 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,1200 | −7 714 | −132 | 937 628 | ||||
| 2021-07-02 | 2021-07-01 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0979 | −102 219 | −1 748 | 7 958 899 | ||||
| 2021-07-02 | 2021-07-01 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,0979 | −28 198 | −482 | 2 171 758 | ||||
| 2021-07-02 | 2021-07-01 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,0979 | −10 575 | −181 | 945 342 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,2764 | −158 961 | −2 746 | 8 061 118 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,2764 | −43 851 | −758 | 2 199 956 | ||||
| 2021-07-02 | 2021-06-30 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,2764 | −16 444 | −284 | 955 917 | ||||
| 2021-06-25 | 2021-06-25 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,8035 | −725 000 | −12 908 | 8 220 079 | ||||
| 2021-06-25 | 2021-06-25 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 17,8035 | −200 000 | −3 561 | 2 243 807 | ||||
| 2021-06-25 | 2021-06-25 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 17,8035 | −75 000 | −1 335 | 972 361 | ||||
| 2021-06-25 | 2021-06-24 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,3749 | −101 158 | −1 859 | 8 945 079 | ||||
| 2021-06-25 | 2021-06-24 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,3749 | −27 906 | −513 | 2 443 807 | ||||
| 2021-06-25 | 2021-06-24 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 18,3749 | −10 465 | −192 | 1 047 361 | ||||
| 2021-06-25 | 2021-06-23 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,2848 | −96 516 | −1 765 | 9 046 237 | ||||
| 2021-06-25 | 2021-06-23 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,2848 | −26 625 | −487 | 2 471 713 | ||||
| 2021-06-25 | 2021-06-23 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 18,2848 | −9 985 | −183 | 1 057 826 | ||||
| 2021-06-21 | 2021-06-18 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,4992 | −291 798 | −5 398 | 9 142 753 | ||||
| 2021-06-21 | 2021-06-18 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,4992 | −80 496 | −1 489 | 2 498 338 | ||||
| 2021-06-21 | 2021-06-18 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 18,4992 | −30 186 | −558 | 1 067 811 | ||||
| 2021-06-21 | 2021-06-17 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 19,1731 | −131 532 | −2 522 | 9 434 551 | ||||
| 2021-06-21 | 2021-06-17 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 19,1731 | −36 284 | −696 | 2 578 834 | ||||
| 2021-06-21 | 2021-06-17 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 19,1731 | −13 607 | −261 | 1 097 997 | ||||
| 2021-06-21 | 2021-06-16 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 19,4032 | −111 325 | −2 160 | 9 566 083 | ||||
| 2021-06-21 | 2021-06-16 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 19,3996 | −34 431 | −668 | 2 615 118 | ||||
| 2021-06-21 | 2021-06-16 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 19,4955 | −12 730 | −248 | 1 111 604 | ||||
| 2021-06-16 | 2021-06-14 | 4 | Durrant Cameron By Cameron Durrant Revocable Trust | HGEN | Common Stock | I | 20,6100 | −49 906 | −1 029 | 30 000 | ||||
| 2021-06-16 | 2021-06-14 | 4 | Durrant Cameron By Cameron Durrant Revocable Trust | HGEN | Common Stock | I | 21,1400 | −5 094 | −108 | 79 906 | ||||
| 2021-06-16 | 2021-06-14 | 4 | Durrant Cameron By Cameron Durrant Revocable Trust | HGEN | Common Stock | I | 20,6000 | −26 441 | −545 | 85 000 | ||||
| 2021-06-16 | 2021-03-01 | 4 | Durrant Cameron By Cameron Durrant Revocable Trust | HGEN | Common Stock | I | 111 441 | 111 441 | ||||||
| 2021-06-16 | 2021-03-01 | 4 | Durrant Cameron | HGEN | Common Stock | D | −111 441 | 0 | ||||||
| 2021-06-09 | 2021-06-08 | 4 | Jordan Edward P. | HGEN | Stock Option (Right to Buy) | D | 9,65 | −14 700 | 73 500 | |||||
| 2021-06-09 | 2021-06-08 | 4 | Jordan Edward P. | HGEN | Common Stock | D | 20,0800 | −14 700 | −295 | 0 | ||||
| 2021-06-09 | 2021-06-08 | 4 | Jordan Edward P. | HGEN | Common Stock | D | 9,6500 | 14 700 | 142 | 14 700 | ||||
| 2021-06-09 | 2021-06-07 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 19,0832 | −42 440 | −810 | 9 677 408 | ||||
| 2021-06-09 | 2021-06-07 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 19,0832 | −25 464 | −486 | 2 649 549 | ||||
| 2021-06-09 | 2021-06-07 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 19,0832 | −12 732 | −243 | 1 124 334 | ||||
| 2021-06-04 | 2021-06-04 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,4635 | −66 886 | −1 235 | 9 719 848 | ||||
| 2021-06-04 | 2021-06-04 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,4635 | −40 132 | −741 | 2 675 013 | ||||
| 2021-06-04 | 2021-06-04 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 18,4635 | −20 066 | −370 | 1 137 066 | ||||
| 2021-06-04 | 2021-06-03 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,3690 | −100 607 | −1 848 | 9 786 734 | ||||
| 2021-06-04 | 2021-06-03 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 18,3690 | −60 365 | −1 109 | 2 715 145 | ||||
| 2021-06-04 | 2021-06-03 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 18,3690 | −30 182 | −554 | 1 157 132 | ||||
| 2021-06-04 | 2021-06-02 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 19,0115 | −40 042 | −761 | 9 887 341 | ||||
| 2021-06-04 | 2021-06-02 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 19,0115 | −24 056 | −457 | 2 775 510 | ||||
| 2021-06-04 | 2021-06-02 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 19,0115 | −12 028 | −229 | 1 187 314 | ||||
| 2021-04-22 | 2021-04-21 | 4 | Kilcoyne Adrian | HGEN | Stock Option (Right to Buy) | D | 14,99 | 155 000 | 155 000 | |||||
| 2021-04-06 | 2021-03-09 | 4/A | NOMIS BAY LTD. | HGEN | Common Stock | D | 17,2374 | −83 568 | −1 440 | 5 632 469 | ||||
| 2021-03-15 | 2021-03-12 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 16,07 | 652 640 | 652 640 | |||||
| 2021-03-11 | 2021-03-11 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 15,4900 | −37 912 | −587 | 5 342 887 | ||||
| 2021-03-11 | 2021-03-11 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 16,0206 | −119 201 | −1 910 | 5 380 799 | ||||
| 2021-03-11 | 2021-03-10 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 16,4646 | −32 469 | −535 | 5 500 000 | ||||
| 2021-03-11 | 2021-03-09 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 17,2374 | −83 568 | −1 440 | 55 632 469 | ||||
| 2021-03-01 | 2021-03-01 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 18,6490 | −14 100 | −263 | 5 616 037 | ||||
| 2021-03-01 | 2021-02-26 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,1793 | −30 003 | −575 | 5 630 137 | ||||
| 2021-03-01 | 2021-02-25 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,1694 | −2 402 | −46 | 5 660 140 | ||||
| 2021-02-24 | 2021-02-24 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,5450 | −25 906 | −506 | 5 662 542 | ||||
| 2021-02-24 | 2021-02-22 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 23,2130 | −77 314 | −1 795 | 5 688 448 | ||||
| 2021-02-19 | 2021-02-19 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 23,4950 | −37 300 | −876 | 5 765 762 | ||||
| 2021-02-19 | 2021-02-18 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 21,6950 | −42 408 | −920 | 5 803 062 | ||||
| 2021-02-19 | 2021-02-17 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,9190 | −9 700 | −193 | 5 845 470 | ||||
| 2021-02-16 | 2021-02-13 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,6810 | −16 423 | −323 | 5 855 170 | ||||
| 2021-02-16 | 2021-02-11 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 21,0090 | −550 | −12 | 5 871 593 | ||||
| 2021-02-10 | 2021-02-10 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 21,3890 | −10 875 | −233 | 5 872 143 | ||||
| 2021-02-10 | 2021-02-09 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 22,3230 | −25 666 | −573 | 5 883 018 | ||||
| 2021-02-10 | 2021-02-08 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 20,6990 | −17 732 | −367 | 5 908 684 | ||||
| 2021-02-04 | 2021-02-04 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 21,8770 | −47 862 | −1 047 | 5 926 416 | ||||
| 2021-02-04 | 2021-02-03 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,2330 | −25 000 | −481 | 5 974 278 | ||||
| 2021-02-04 | 2021-02-02 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 20,0290 | −722 | −14 | 5 999 278 | ||||
| 2021-01-27 | 2021-01-25 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 18,7800 | −70 000 | −1 315 | 6 000 000 | ||||
| 2021-01-27 | 2021-01-25 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,2320 | −23 140 | −445 | 6 070 000 | ||||
| 2021-01-27 | 2021-01-22 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 20,0760 | −71 892 | −1 443 | 6 093 140 | ||||
| 2021-01-21 | 2021-01-20 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 18,3711 | −2 500 | −46 | 6 165 032 | ||||
| 2021-01-21 | 2021-01-19 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 21,0825 | −6 000 | −126 | 6 167 532 | ||||
| 2021-01-19 | 2021-01-19 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,8100 | −50 000 | −990 | 6 173 532 | ||||
| 2021-01-19 | 2021-01-15 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 18,2290 | −30 000 | −547 | 6 223 532 | ||||
| 2021-01-19 | 2021-01-14 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 18,0660 | −25 000 | −452 | 6 253 532 | ||||
| 2021-01-13 | 2021-01-12 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 18,4272 | −14 577 | −269 | 6 278 532 | ||||
| 2021-01-13 | 2021-01-11 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,0000 | −10 423 | −198 | 6 293 109 | ||||
| 2020-12-31 | 2020-12-28 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 22,2020 | −500 | −11 | 6 303 532 | ||||
| 2020-12-28 | 2020-12-22 | 4/A | NOMIS BAY LTD. | HGEN | Common Stock | D | 20,0197 | −50 000 | −1 001 | 6 357 433 | ||||
| 2020-12-28 | 2020-12-24 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 22,0490 | −8 401 | −185 | 6 304 032 | ||||
| 2020-12-28 | 2020-12-23 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 21,0860 | −45 000 | −949 | 6 312 433 | ||||
| 2020-12-23 | 2020-12-22 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 50 000,0000 | −50 000 | −2 500 000 | 6 357 433 | ||||
| 2020-12-23 | 2020-12-21 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 19,4578 | −25 000 | −486 | 6 407 433 | ||||
| 2020-12-23 | 2020-12-18 | 4 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 15,00 | −46 | 0 | |||||
| 2020-12-23 | 2020-12-18 | 4 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 15,00 | −157 | 46 | |||||
| 2020-12-23 | 2020-12-18 | 4 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 15,00 | −100 | 203 | |||||
| 2020-12-23 | 2020-12-18 | 4 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 15,00 | −70 | 303 | |||||
| 2020-12-23 | 2020-12-18 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 15,0000 | −37 300 | −560 | 6 432 433 | ||||
| 2020-12-23 | 2020-12-18 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 15,7627 | −62 700 | −988 | 6 469 733 | ||||
| 2020-12-23 | 2020-12-17 | 4 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 15,00 | 0,1533 | −46 | −0 | 373 | |||
| 2020-12-23 | 2020-12-15 | 4 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 15,00 | 0,4000 | −157 | −0 | 327 | |||
| 2020-12-23 | 2020-12-10 | 4 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 15,00 | 0,1000 | −100 | −0 | 170 | |||
| 2020-12-23 | 2020-12-07 | 4 | NOMIS BAY LTD. | HGEN | Call Option (Obligation to sell) | D | 15,00 | 0,1000 | −70 | −0 | 70 | |||
| 2020-10-07 | 2020-10-05 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 12,14 | 82 622 | 82 622 | |||||
| 2020-10-02 | 2020-09-30 | 4 | BARLIANT RONALD | HGEN | Stock Option (Right to Buy) | D | 10,64 | 8,0400 | 1 803 | 14 | 1 803 | |||
| 2020-10-02 | 2020-09-30 | 4 | Buxton Cheryl | HGEN | Common Stock, $0.001 par value | D | 10,6400 | 1 284 | 14 | 4 364 | ||||
| 2020-10-02 | 2020-09-30 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 10,6400 | 1 519 | 16 | 84 986 | ||||
| 2020-09-22 | 2020-09-18 | 4 | Chappell Dale | HGEN | Stock Option (right to buy) | D | 9,65 | 9,6500 | 133 760 | 1 291 | 133 760 | |||
| 2020-09-22 | 2020-09-18 | 4 | Tousley David L. | HGEN | Stock Option (Right to Buy) | D | 9,65 | 62 700 | 62 700 | |||||
| 2020-09-22 | 2020-09-18 | 4 | MORRIS TIMOTHY E | HGEN | Stock Option (Right to Buy) | D | 9,65 | 151 316 | 151 316 | |||||
| 2020-09-22 | 2020-09-18 | 4 | Jordan Edward P. | HGEN | Stock Option (Right to Buy) | D | 9,65 | 88 200 | 88 200 | |||||
| 2020-08-12 | 2020-08-10 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 5,0350 | −17 100 | −86 | 32 662 170 | ||||
| 2020-07-30 | 2020-07-28 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 5,6550 | −10 000 | −57 | 32 679 270 | ||||
| 2020-07-21 | 2020-07-20 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 5,0000 | −261 915 | −1 310 | 32 689 270 | ||||
| 2020-07-21 | 2020-07-17 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 5,0050 | −38 085 | −191 | 32 951 185 | ||||
| 2020-07-02 | 2020-06-30 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 4,9130 | −3 000 | −15 | 32 989 270 | ||||
| 2020-06-17 | 2020-06-16 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 5,7329 | −35 000 | −201 | 32 992 270 | ||||
| 2020-06-17 | 2020-06-15 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 5,5049 | −30 000 | −165 | 33 027 270 | ||||
| 2020-06-12 | 2020-06-10 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 3,4770 | −5 000 | −17 | 33 057 270 | ||||
| 2020-06-12 | 2020-06-09 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 3,6510 | −35 000 | −128 | 33 062 270 | ||||
| 2020-06-12 | 2020-06-04 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 3,0250 | −106 000 | −321 | 33 097 270 | ||||
| 2020-06-12 | 2020-06-03 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 2,9830 | −101 010 | −301 | 33 203 270 | ||||
| 2020-06-12 | 2020-06-02 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 2,1810 | −263 250 | −574 | 33 304 280 | ||||
| 2020-06-12 | 2020-03-20 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 2,0000 | −6 000 | −12 | 33 567 530 | ||||
| 2020-05-22 | 2020-05-20 | 4 | BARLIANT RONALD | HGEN | Common Stock, $0.001 par value | D | 0,8600 | 26 847 | 23 | 449 351 | ||||
| 2020-05-21 | 2020-05-20 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 0,86 | 0,8600 | 250 000 | 215 | 250 000 | |||
| 2020-04-07 | 2020-04-01 | 4/A | Savage Robert G. | HGEN | Stock Option (Right to Buy) | D | 1,20 | 1,2000 | 21 022 | 25 | 21 022 | |||
| 2020-04-07 | 2020-04-01 | 4/A | BARLIANT RONALD | HGEN | Stock Option (Right to Buy) | D | 1,20 | 1,2000 | 15 340 | 18 | 15 340 | |||
| 2020-04-07 | 2020-04-02 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Convertible Note | I | 0,36 | 500 000,0000 | 0 | |||||
| 2020-04-07 | 2020-04-02 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 0,3600 | 1 583 333 | 570 | 49 636 917 | ||||
| 2020-04-07 | 2018-09-20 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Convertible Note | I | 0,36 | 500 000,0000 | ||||||
| 2020-04-02 | 2020-04-01 | 4 | BARLIANT RONALD | HGEN | Stock Option (Right to Buy) | D | 1,20 | 1,2000 | 48 214 | 58 | 48 214 | |||
| 2020-04-02 | 2020-04-01 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 1,2000 | 13 750 | 16 | 417 338 | ||||
| 2020-04-02 | 2020-04-01 | 4 | Buxton Cheryl | HGEN | Common Stock, $0.001 par value | D | 1,2000 | 10 824 | 13 | 15 400 | ||||
| 2020-04-02 | 2020-04-01 | 4 | Savage Robert G. | HGEN | Stock Option (Right to Buy) | D | 1,20 | 1,2000 | 66 071 | 79 | 66 071 | |||
| 2020-01-29 | 2020-01-28 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 0,40 | 0,4000 | 318 103 | 127 | 318 103 | |||
| 2020-01-24 | 2020-01-22 | 4 | BARLIANT RONALD | HGEN | Stock Option (Right to Buy) | D | 0,38 | 0,3800 | 50 000 | 19 | 50 000 | |||
| 2020-01-24 | 2020-01-22 | 4 | Buxton Cheryl | HGEN | Common Stock, $0.001 par value | D | 0,3800 | 4 576 | 2 | 4 576 | ||||
| 2020-01-24 | 2020-01-22 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 0,3800 | 43 421 | 16 | 403 588 | ||||
| 2019-12-16 | 2019-12-16 | 4 | Buxton Cheryl | HGEN | Stock Option (Right to Buy) | D | 0,45 | 715 877 | 715 877 | |||||
| 2019-11-12 | 2019-11-08 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 0,7000 | 23 571 | 16 | 360 167 | ||||
| 2019-11-12 | 2019-11-08 | 4 | BARLIANT RONALD | HGEN | Stock Option (Right to Buy) | D | 0,70 | 0,5100 | 26 470 | 13 | 26 470 | |||
| 2019-07-31 | 2019-07-29 | 4 | BARLIANT RONALD | HGEN | Common Stock, $0.001 par value | D | 0,8500 | 15 882 | 13 | 422 504 | ||||
| 2019-07-31 | 2019-07-29 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 0,8500 | 19 412 | 17 | 336 596 | ||||
| 2019-06-05 | 2019-06-04 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 1,2500 | 8 000 | 10 | 557 207 | ||||
| 2019-06-04 | 2019-05-31 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 586 027 | 48 053 584 | ||||||
| 2019-06-04 | 2019-05-31 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 591 248 | 47 467 557 | ||||||
| 2019-05-31 | 2019-05-31 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 235 624 | 549 207 | ||||||
| 2019-05-31 | 2019-05-31 | 4 | BARLIANT RONALD | HGEN | Common Stock, $0.001 par value | D | 236 499 | 406 622 | ||||||
| 2019-05-30 | 2019-05-29 | 4 | Boehm Rainer J. | HGEN | Stock Option (Right to Buy) | D | 0,66 | −238 625 | 477 252 | |||||
| 2019-05-30 | 2019-05-29 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 0,6650 | 238 625 | 159 | 317 184 | ||||
| 2019-05-16 | 2019-05-14 | 4 | Savage Robert G. | HGEN | Stock Option (Right to Buy) | D | 0,66 | −100 000 | 615 877 | |||||
| 2019-05-16 | 2019-05-14 | 4 | Savage Robert G. | HGEN | Common Stock, $0.001 par value | D | 0,6650 | 100 000 | 66 | 199 869 | ||||
| 2019-04-25 | 2019-04-23 | 4 | Durrant Cameron | HGEN | Employee Stock Option Exercise (Right to Buy) | D | 0,66 | −75 000 | 8 359 771 | |||||
| 2019-04-25 | 2019-04-23 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 0,6650 | 75 000 | 50 | 313 583 | ||||
| 2019-04-02 | 2019-03-29 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 1,3500 | 12 222 | 16 | 78 559 | ||||
| 2019-04-02 | 2019-03-29 | 4 | Savage Robert G. | HGEN | Common Stock, $0.001 par value | D | 1,3500 | 13 704 | 19 | 99 869 | ||||
| 2019-04-02 | 2019-03-29 | 4 | BARLIANT RONALD | HGEN | Common Stock, $0.001 par value | D | 1,3500 | 10 000 | 14 | 170 123 | ||||
| 2019-03-11 | 2019-03-08 | 4 | Durrant Cameron | HGEN | Employee Stock Option Exercise (Right to Buy) | D | 0,66 | −75 000 | 8 434 771 | |||||
| 2019-03-11 | 2019-03-08 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 0,6650 | 75 000 | 50 | 238 583 | ||||
| 2019-01-28 | 2019-01-25 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 0,84 | 142 857 | 142 857 | |||||
| 2019-01-28 | 2019-01-25 | 4 | Jester J Gregory | HGEN | Stock Option (Right to Buy) | D | 0,84 | 86 111 | 86 111 | |||||
| 2019-01-07 | 2019-01-03 | 4 | Savage Robert G. | HGEN | Common Stock, $0.001 par value | D | 0,7400 | 20 946 | 16 | 86 165 | ||||
| 2019-01-07 | 2019-01-03 | 4 | BARLIANT RONALD | HGEN | Common Stock, $0.001 par value | D | 0,7400 | 18 243 | 13 | 160 123 | ||||
| 2019-01-07 | 2019-01-03 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 0,7400 | 18 243 | 13 | 66 337 | ||||
| 2018-12-14 | 2018-12-14 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 0,8160 | 4 000 | 3 | 163 583 | ||||
| 2018-12-14 | 2018-12-12 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 0,8219 | 2 000 | 2 | 159 583 | ||||
| 2018-12-12 | 2018-12-11 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 0,7570 | 2 500 | 2 | 157 583 | ||||
| 2018-12-12 | 2018-12-10 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 0,7500 | 2 500 | 2 | 155 083 | ||||
| 2018-12-10 | 2018-12-07 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 0,7390 | 7 000 | 5 | 152 583 | ||||
| 2018-12-10 | 2018-12-06 | 4 | Durrant Cameron | HGEN | Common Stock, $0.001 par value | D | 0,7320 | 10 000 | 7 | 145 583 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Savage Robert G. | HGEN | Common Stock, $0.001 par value | D | 0,6400 | 24 219 | 16 | 65 219 | ||||
| 2018-10-02 | 2018-09-28 | 4 | BARLIANT RONALD | HGEN | Common Stock, $0.001 par value | D | 0,6400 | 21 094 | 14 | 141 880 | ||||
| 2018-10-02 | 2018-09-28 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 0,6400 | 21 094 | 14 | 48 094 | ||||
| 2018-08-09 | 2018-08-07 | 4 | BARLIANT RONALD | HGEN | Common Stock, $0.001 par value | D | 0,5000 | 27 000 | 14 | 120 786 | ||||
| 2018-08-09 | 2018-08-07 | 4 | Savage Robert G. | HGEN | Common Stock, $0.001 par value | D | 0,5000 | 31 000 | 16 | 41 000 | ||||
| 2018-08-09 | 2018-08-07 | 4 | Boehm Rainer J. | HGEN | Common Stock, $0.001 par value | D | 0,5000 | 27 000 | 14 | 27 000 | ||||
| 2018-03-13 | 3 | Savage Robert G. | HGEN | Common Stock, $0.001 par value | D | 20 000 | ||||||||
| 2018-03-13 | 3 | Savage Robert G. | HGEN | Common Stock, $0.001 par value | D | 20 000 | ||||||||
| 2018-03-13 | 2018-03-09 | 4 | Boehm Rainer J. | HGEN | Stock Option (Right to Buy) | D | 0,66 | 715 877 | 715 877 | |||||
| 2018-03-13 | 2018-03-09 | 4 | Jester J Gregory | HGEN | Stock Option (Right to Buy) | D | 0,66 | 284 313 | 284 313 | |||||
| 2018-03-13 | 2018-03-09 | 4 | Jester J Gregory | HGEN | Stock Option (Right to Buy) | D | 0,66 | 1 073 815 | 1 223 815 | |||||
| 2018-03-13 | 2018-03-09 | 4 | BARLIANT RONALD | HGEN | Stock Option (Right to Buy) | D | 0,66 | 156 863 | 156 863 | |||||
| 2018-03-13 | 2018-03-09 | 4 | BARLIANT RONALD | HGEN | Stock Option (Right to Buy) | D | 0,66 | 715 877 | 715 877 | |||||
| 2018-03-13 | 2018-03-09 | 4 | Durrant Cameron | HGEN | Stock Option (Right to Buy) | D | 0,66 | 7 466 749 | 8 509 771 | |||||
| 2018-03-13 | 2018-03-09 | 4 | Savage Robert G. | HGEN | Stock Option (Right to Buy) | D | 0,66 | 715 877 | 715 877 | |||||
| 2018-03-13 | 2018-03-09 | 4 | MORRIS TIMOTHY E | HGEN | Stock Option (Right to Buy) | D | 0,66 | 88 235 | 88 235 | |||||
| 2018-03-13 | 2018-03-09 | 4 | MORRIS TIMOTHY E | HGEN | Stock Option (Right to Buy) | D | 0,66 | 715 877 | 715 877 | |||||
| 2018-03-07 | 2017-09-05 | 4 | Jester J Gregory | HGEN | Employee Stock Option (right to buy) | D | 0,33 | 150 000 | 150 000 | |||||
| 2018-03-05 | 2018-02-27 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 0,2800 | 29 893 424 | 8 370 | 33 573 530 | ||||
| 2018-03-01 | 2018-02-27 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 0,0937 | 32 028 669 | 3 001 | 46 876 309 | ||||
| 2018-03-01 | 2018-02-27 | 4 | Chappell Dale By Cheval Holdings, Ltd. | HGEN | Common Stock, $0.001 par value | I | 12 812 322 | 14 847 640 | ||||||
| 2018-03-01 | 2018-02-27 | 4 | Chappell Dale By Black Horse Capital Master Fund Ltd. | HGEN | Common Stock, $0.001 par value | I | 11 957 369 | 13 997 832 | ||||||
| 2018-03-01 | 2018-02-27 | 4 | Chappell Dale By Black Horse Capital LP | HGEN | Common Stock, $0.001 par value | I | 5 123 733 | 5 996 710 | ||||||
| 2017-09-05 | 2017-08-30 | 4 | NOMIS BAY LTD. | HGEN | Common Stock | D | 0,4600 | −38 900 | −18 | 3 680 106 | ||||
| 2017-02-22 | 2017-02-21 | 4 | Lam Morgan | KBIO | Employee Stock Option (right to buy) | D | 2,92 | 100 000 | 100 000 | |||||
| 2017-02-22 | 2017-02-21 | 4 | Tousley David L. | KBIO | Employee Stock Option (right to buy) | D | 2,92 | 100 000 | 100 000 | |||||
| 2016-09-15 | 2016-09-13 | 4 | BARLIANT RONALD | KBIO | Stock Option (right to buy) | D | 3,38 | 100 000 | 100 000 | |||||
| 2016-09-15 | 2016-09-13 | 4 | MORRIS TIMOTHY E | KBIO | Stock Option (right to buy) | D | 3,38 | 100 000 | 100 000 | |||||
| 2016-09-15 | 2016-09-13 | 4 | Chappell Dale | KBIO | Stock Option (Right to Buy) | D | 3,38 | 100 000 | 100 000 | |||||
| 2016-09-15 | 2016-09-13 | 4 | Durrant Cameron | KBIO | Stock Option (right to buy) | D | 3,38 | 1 043 022 | 1 043 022 | |||||
| 2016-09-15 | 2016-09-13 | 4 | Friedberg Ezra M | KBIO | Stock Option (right to buy) | D | 3,38 | 100 000 | 100 000 | |||||
| 2016-09-15 | 2016-09-13 | 4 | Lam Morgan | KBIO | Stock Option (right to buy) | D | 3,38 | 100 000 | 100 000 | |||||
| 2016-08-29 | 2016-08-26 | 4 | Shkreli Martin | KBIO | Common Stock | D | 3,1000 | −309 723 | −960 | 0 | ||||
| 2016-08-29 | 2016-08-25 | 4 | Shkreli Martin | KBIO | Common Stock | D | 3,1000 | −1 913 206 | −5 931 | 309 723 | ||||
| 2016-07-13 | 3 | NOMIS BAY LTD. | KBIOQ | Common Stock | D | 7 438 012 | ||||||||
| 2016-07-13 | 3 | NOMIS BAY LTD. | KBIOQ | Common Stock | D | 7 438 012 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 984 076 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital LP | KBIO | Common Stock, par value $0.001 | I | 5 821 735 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 989 221 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital LP | KBIO | Common Stock, par value $0.001 | I | 5 821 735 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 984 076 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital LP | KBIO | Common Stock, par value $0.001 | I | 5 821 735 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 984 076 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 989 221 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 984 076 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital LP | KBIO | Common Stock, par value $0.001 | I | 5 821 735 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 989 221 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital LP | KBIO | Common Stock, par value $0.001 | I | 5 821 735 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 989 221 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 984 076 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital LP | KBIO | Common Stock, par value $0.001 | I | 5 821 735 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 989 221 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By: Cheval Holdings, Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 984 076 | ||||||||
| 2016-07-11 | 3 | Black Horse Capital Master Fund Ltd. By Black Horse Capital Master Fund Ltd. | KBIO | Common Stock, par value $0.001 | I | 6 989 221 | ||||||||
| 2016-07-05 | 2016-06-30 | 4 | BARLIANT RONALD | KBIOQ | Common Stock | D | 93 786 | 93 786 | ||||||
| 2016-07-05 | 2016-06-30 | 4 | Durrant Cameron | KBIOQ | Common Stock | D | 135 583 | 135 583 | ||||||
| 2015-12-18 | 2015-12-16 | 4/A | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 29,3200 | 3 410 | 100 | 178 210 | ||||
| 2015-12-18 | 2015-12-16 | 4/A | Anthion Partners II LLC | KBIO | Common Stock | D | 29,3200 | 3 410 | 100 | 178 210 | ||||
| 2015-12-18 | 2015-12-16 | 4 | Fernandez Thomas Edward | KBIO | Common Stock | D | 29,3200 | 6 821 | 200 | 6 821 | ||||
| 2015-12-18 | 2015-12-16 | 4 | BIESTEK MAREK | KBIO | Common Stock | D | 29,3200 | 10 000 | 293 | 250 000 | ||||
| 2015-12-18 | 2015-12-16 | 4 | Harrison Michael Wayne | KBIO | Common Stock | D | 29,3200 | 1 705 | 50 | 1 705 | ||||
| 2015-12-17 | 2015-12-16 | 4 | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 29,3200 | 3 410 | 100 | 378 210 | ||||
| 2015-12-17 | 2015-12-16 | 4 | Anthion Partners II LLC | KBIO | Common Stock | D | 29,3200 | 3 410 | 100 | 378 210 | ||||
| 2015-11-24 | 2015-11-24 | 4 | Shkreli Martin | KBIO | Common Stock | D | 38,1500 | 5 000 | 191 | 2 075 200 | ||||
| 2015-11-23 | 2015-11-20 | 4 | Shkreli Martin | KBIO | Common Stock | D | 18,8800 | 5 000 | 94 | 2 070 200 | ||||
| 2015-11-19 | 3 | BIESTEK MAREK | KBIO | Common Stock | D | 0 | ||||||||
| 2015-11-19 | 2015-11-18 | 4 | Shkreli Martin | KBIO | Common Stock | D | 2,0200 | 440 000 | 889 | 2 065 200 | ||||
| 2015-11-19 | 2015-11-18 | 4 | BIESTEK MAREK | KBIO | Common Stock | D | 2,0400 | 40 000 | 82 | 240 000 | ||||
| 2015-11-19 | 2015-11-17 | 4 | BIESTEK MAREK | KBIO | Common Stock | D | 1,8300 | 135 000 | 247 | 200 000 | ||||
| 2015-11-19 | 2015-11-16 | 4 | BIESTEK MAREK | KBIO | Common Stock | D | 1,3600 | 65 000 | 88 | 65 000 | ||||
| 2015-11-19 | 2015-11-18 | 4 | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 2,1300 | 150 000 | 320 | 574 800 | ||||
| 2015-11-19 | 2015-11-18 | 4 | Anthion Partners II LLC | KBIO | Common Stock | D | 2,1300 | 150 000 | 320 | 574 800 | ||||
| 2015-11-18 | 3/A | Moradi David | KBIO | Common Stock | D | 67 937 | ||||||||
| 2015-11-18 | 3/A | Moradi David Through Anthion Partners II LLC | KBIO | Common Stock | I | 67 937 | ||||||||
| 2015-11-18 | 2015-11-17 | 4/A | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 1,6900 | 113 800 | 192 | 424 800 | ||||
| 2015-11-18 | 2015-11-17 | 4/A | Anthion Partners II LLC | KBIO | Common Stock | D | 1,6900 | 113 800 | 192 | 424 800 | ||||
| 2015-11-18 | 2015-11-16 | 4/A | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 1,7600 | 17 100 | 30 | 311 000 | ||||
| 2015-11-18 | 2015-11-16 | 4/A | Anthion Partners II LLC | KBIO | Common Stock | D | 1,7600 | 17 100 | 30 | 311 000 | ||||
| 2015-11-18 | 2015-11-16 | 4/A | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 1,2600 | 225 963 | 285 | 293 900 | ||||
| 2015-11-18 | 2015-11-16 | 4/A | Anthion Partners II LLC | KBIO | Common Stock | D | 1,2600 | 225 963 | 285 | 293 900 | ||||
| 2015-11-18 | 3 | Anthion Partners II LLC | KBIO | Common Stock | D | 203 811 | ||||||||
| 2015-11-18 | 3 | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 203 811 | ||||||||
| 2015-11-18 | 3 | Anthion Partners II LLC | KBIO | Common Stock | D | 203 811 | ||||||||
| 2015-11-18 | 3 | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 203 811 | ||||||||
| 2015-11-18 | 3 | Shkreli Martin | KBIO | Common Stock | D | 828 170 | ||||||||
| 2015-11-18 | 3 | Shkreli Martin | KBIO | Common Stock | D | 828 170 | ||||||||
| 2015-11-18 | 2015-11-17 | 4 | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 1,6900 | 113 800 | 192 | 424 800 | ||||
| 2015-11-18 | 2015-11-17 | 4 | Anthion Partners II LLC | KBIO | Common Stock | D | 1,6900 | 113 800 | 192 | 424 800 | ||||
| 2015-11-18 | 2015-11-16 | 4 | Anthion Partners II LLC | KBIO | Common Stock | D | 1,7600 | 17 100 | 30 | 311 000 | ||||
| 2015-11-18 | 2015-11-16 | 4 | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 1,7600 | 17 100 | 30 | 311 000 | ||||
| 2015-11-18 | 2015-11-16 | 4 | Anthion Partners II LLC Through Anthion Partners II LLC | KBIO | Common Stock | I | 1,2600 | 225 963 | 285 | 293 900 | ||||
| 2015-11-18 | 2015-11-16 | 4 | Anthion Partners II LLC | KBIO | Common Stock | D | 1,2600 | 225 963 | 285 | 293 900 | ||||
| 2015-11-18 | 2015-11-17 | 4 | Shkreli Martin | KBIO | Common Stock | D | 2,4300 | 7 000 | 17 | 1 625 200 | ||||
| 2015-11-18 | 2015-11-17 | 4 | Shkreli Martin | KBIO | Common Stock | D | 1,9300 | 606 677 | 1 171 | 1 618 200 | ||||
| 2015-11-18 | 2015-11-16 | 4 | Shkreli Martin | KBIO | Common Stock | D | 1,4300 | 97 269 | 139 | 1 011 523 | ||||
| 2015-11-18 | 2015-11-16 | 4 | Shkreli Martin | KBIO | Common Stock | D | 0,6100 | 500 169 | 305 | 914 254 | ||||
| 2015-11-10 | 2015-11-09 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,95 | 1 875 | 1 875 | |||||
| 2015-10-28 | 2015-10-28 | 4 | MARTELL RON | KBIO | Stock Option (right to buy) | D | 1,90 | 3 125 | 3 125 | |||||
| 2015-10-08 | 2015-10-08 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 2,31 | 1 875 | 1 875 | |||||
| 2015-09-28 | 2015-09-28 | 4 | MARTELL RON | KBIO | Stock Option (right to buy) | D | 1,93 | 3 125 | 3 125 | |||||
| 2015-09-22 | 2015-08-28 | 4 | MARTELL RON | KBIO | Stock Option (right to buy) | D | 2,01 | 3 125 | 3 125 | |||||
| 2015-09-22 | 2015-09-08 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 3,45 | 1 875 | 1 875 | |||||
| 2015-08-11 | 2015-08-10 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 2,05 | 1 875 | 1 875 | |||||
| 2015-07-30 | 2015-07-30 | 4 | MARTELL RON | KBIO | Stock Option (right to buy) | D | 2,16 | 3 125 | 3 125 | |||||
| 2015-07-14 | 2015-07-10 | 4 | Smaldone Alsup Laurie | KBIO | Stock Option (right to buy) | D | 3,68 | 5 000 | 5 000 | |||||
| 2015-07-14 | 2015-07-10 | 4 | BAFFI ROBERT | KBIO | Stock Option (right to buy) | D | 3,68 | 5 000 | 5 000 | |||||
| 2015-07-14 | 2015-07-10 | 4 | GILBERT DENISE | KBIO | Stock Option (right to buy) | D | 3,68 | 5 000 | 5 000 | |||||
| 2015-07-14 | 2015-07-10 | 4 | WITHY RAYMOND M | KBIO | Stock Option (right to buy) | D | 3,68 | 5 000 | 5 000 | |||||
| 2015-07-14 | 2015-07-10 | 4 | LOVE TED W | KBIO | Stock Option (right to buy) | D | 3,68 | 5 000 | 5 000 | |||||
| 2015-07-14 | 2015-07-10 | 4 | LYONS GARY A | KBIO | Stock Option (right to buy) | D | 3,68 | 5 000 | 5 000 | |||||
| 2015-07-08 | 2015-07-07 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,49 | 15 000 | 15 000 | |||||
| 2015-06-30 | 2015-06-29 | 4 | MARTELL RON | KBIO | Stock Option (right to buy) | D | 0,49 | 25 000 | 25 000 | |||||
| 2015-06-08 | 2015-06-08 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,57 | 15 000 | 15 000 | |||||
| 2015-05-28 | 2015-05-28 | 4 | MARTELL RON | KBIO | Stock Option (right to buy) | D | 0,53 | 25 000 | 25 000 | |||||
| 2015-05-08 | 2015-05-07 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,50 | 15 000 | 15 000 | |||||
| 2015-04-27 | 2015-04-22 | 4 | MARTELL RON | KBIO | Stock Option (right to buy) | D | 0,57 | 30 000 | 30 000 | |||||
| 2015-04-27 | 2015-04-22 | 4 | MARTELL RON | KBIO | Restricted Stock Units | D | 30 000 | 30 000 | ||||||
| 2015-04-08 | 2015-04-07 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,47 | 15 000 | 15 000 | |||||
| 2015-03-13 | 2015-01-20 | 4/A | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,44 | 15 000 | 15 000 | |||||
| 2015-03-10 | 2015-03-10 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,56 | 15 000 | 15 000 | |||||
| 2015-02-18 | 2015-02-16 | 4 | Joseph Donald | KBIO | Stock Options (right to buy) | D | 0,45 | 300 000 | 300 000 | |||||
| 2015-02-18 | 2015-02-16 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,45 | 300 000 | 300 000 | |||||
| 2015-02-18 | 2015-02-16 | 4 | Yarranton Geoffrey Thomas | KBIO | Stock Options (right to buy) | D | 0,45 | 300 000 | 300 000 | |||||
| 2015-02-09 | 2015-02-06 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,42 | 15 000 | 15 000 | |||||
| 2015-01-21 | 2015-01-20 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 0,44 | 15 000 | 15 000 | |||||
| 2014-12-01 | 2014-11-25 | 4 | BAFFI ROBERT | KBIO | Stock Option (right to buy) | D | 1,87 | 40 000 | 40 000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | LOVE TED W | KBIO | Stock Option (right to buy) | D | 2,10 | 20 000 | 20 000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | LAWLIS V BRYAN | KBIO | Stock Option (right to buy) | D | 2,10 | 20 000 | 20 000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | WITHY RAYMOND M | KBIO | Stock Option (right to buy) | D | 2,10 | 20 000 | 20 000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | LYONS GARY A | KBIO | Stock Option (right to buy) | D | 2,10 | 20 000 | 20 000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | GILBERT DENISE | KBIO | Stock Option (right to buy) | D | 2,10 | 20 000 | 20 000 | |||||
| 2014-06-20 | 2014-06-18 | 4 | Smaldone Alsup Laurie | KBIO | Stock Option (right to buy) | D | 2,10 | 20 000 | 20 000 | |||||
| 2014-01-22 | 2014-01-19 | 4 | Joseph Donald | KBIO | Stock Option (right to buy) | D | 5,41 | 40 000 | 40 000 | |||||
| 2014-01-22 | 2014-01-19 | 4 | Yarranton Geoffrey Thomas | KBIO | Stock Option (right to buy) | D | 5,41 | 75 000 | 75 000 | |||||
| 2014-01-22 | 2014-01-19 | 4 | Molfino Nestor | KBIO | Stock Option (right to buy) | D | 5,41 | 150 000 | 150 000 | |||||
| 2014-01-22 | 2014-01-21 | 4 | Pritchard David | KBIO | Stock Option (right to buy) | D | 5,36 | 250 000 | 250 000 | |||||
| 2013-10-23 | 2013-10-22 | 4 | CROSS HERB | KBIO | Stock Option (right to buy) | D | 4,15 | 150 000 | 150 000 | |||||
| 2013-10-23 | 2013-10-22 | 4 | Smaldone Alsup Laurie | KBIO | Stock Option (right to buy) | D | 4,15 | 20 000 | 20 000 | |||||
| 2013-09-03 | 2013-08-29 | 4 | LAWLIS V BRYAN | KBIO | Stock Option (right to buy) | D | 5,57 | 20 000 | 20 000 | |||||
| 2013-08-01 | 2013-07-30 | 4 | Joseph Donald | KBIO | Stock Option (right to buy) | D | 5,75 | 125 000 | 125 000 | |||||
| 2013-05-03 | 2013-05-01 | 4 | HENNER DENNIS | KBIO | Stock Option (Right to Buy) | D | 6,00 | 15 000 | 15 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | HEALY JAMES | KBIO | Stock Option (right to buy) | D | 6,00 | 15 000 | 15 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | WITHY RAYMOND M | KBIO | Stock Option (right to buy) | D | 6,00 | 15 000 | 15 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | LOVE TED W | KBIO | Stock Option (right to buy) | D | 6,00 | 15 000 | 15 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | LYONS GARY A | KBIO | Stock Option (right to buy) | D | 6,00 | 15 000 | 15 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | GILBERT DENISE | KBIO | Stock Option (right to buy) | D | 6,00 | 15 000 | 15 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | Cooper Jeffrey H | KBIO | Stock Option (right to buy) | D | 6,00 | −60 000 | 60 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | Molfino Nestor | KBIO | Stock Option (right to buy) | D | 6,00 | −90 000 | 90 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | Yarranton Geoffrey Thomas | KBIO | Stock Option (right to buy) | D | 6,00 | 75 000 | 75 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | Smith Brigitte | KBIO | Stock Option (right to buy) | D | 6,00 | 15 000 | 15 000 | |||||
| 2013-05-02 | 2013-04-30 | 4 | Pritchard David | KBIO | Stock Option (right to buy) | D | 6,00 | 150 000 | 150 000 | |||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series E Preferred Stock | I | −1 207 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series E Preferred Stock | I | −80 731 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series E Preferred Stock | I | −643 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series D Preferred Stock | I | −2 565 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series D Preferred Stock | I | −171 450 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series D Preferred Stock | I | −1 367 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series C Preferred Stock | I | −3 143 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series C Preferred Stock | I | −210 056 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series C Preferred Stock | I | −1 675 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series B-2 Preferred Stock | I | −9 982 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series B-2 Preferred Stock | I | −653 356 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series B-2 Preferred Stock | I | −19 120 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series B-1 Preferred Stock | I | −5 231 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series B-1 Preferred Stock | I | −341 236 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series B-1 Preferred Stock | I | −11 226 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series A Preferred Stock | I | −2 851 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series A Preferred Stock | I | −185 996 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Series A Preferred Stock | I | −6 118 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 1 392 | 31 415 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 93 129 | 2 072 914 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 742 | 43 767 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 2 918 | 30 023 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 195 088 | 1 979 785 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 1 555 | 43 025 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 3 440 | 27 105 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 229 904 | 1 784 697 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 1 833 | 41 470 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 9 982 | 23 665 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 653 356 | 1 554 793 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 19 120 | 39 637 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 5 231 | 13 683 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 341 236 | 901 437 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 11 226 | 20 517 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 2 851 | 8 452 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 185 996 | 560 201 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HEALY JAMES | KBIO | Common Stock | I | 6 118 | 9 291 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | DEVELOPMENT BANK OF JAPAN INC. | KBIO | Series D Preferred Stock | D | −431 973 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | DEVELOPMENT BANK OF JAPAN INC. | KBIO | Common Stock | D | 491 530 | 491 530 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | BAXTER INTERNATIONAL INC | KBIO | Series D Preferred Stock | D | −842 435 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | BAXTER INTERNATIONAL INC | KBIO | Common Stock | D | 958 583 | 958 583 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Sanofi by wholly-owned subsidiary Genzyme Corp. | KBIO | Preferred Shares | I | −431 973 | 0 | ||||||
| 2013-02-07 | 2013-01-31 | 4 | Sanofi by wholly-owned subsidiary Genzyme Corp. | KBIO | Common Stock | I | 8,0000 | 87 500 | 700 | 579 030 | ||||
| 2013-02-07 | 2013-02-05 | 4 | HENNER DENNIS | KBIO | Series D Preferred Stock | I | −275 539 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HENNER DENNIS | KBIO | Series C Preferred Stock | I | −337 622 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HENNER DENNIS | KBIO | Series B-2 Preferred Stock | I | −1 949 879 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HENNER DENNIS | KBIO | Common Stock | I | 313 527 | 2 632 928 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HENNER DENNIS | KBIO | Common Stock | I | 369 522 | 2 319 401 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | HENNER DENNIS | KBIO | Common Stock | I | 1 949 879 | 1 949 879 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | EVNIN LUKE | KBIO | Series D Preferred Stock | I | −275 539 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | EVNIN LUKE | KBIO | Series C Preferred Stock | I | −337 622 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | EVNIN LUKE | KBIO | Series B-2 Preferred Stock | I | −1 949 879 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | EVNIN LUKE | KBIO | Common Stock | I | 313 527 | 2 632 928 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | EVNIN LUKE | KBIO | Common Stock | I | 369 522 | 2 319 401 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | EVNIN LUKE | KBIO | Common Stock | I | 1 949 879 | 1 949 879 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Alloy Ventures 2000, LLC | KBIO | Series E Preferred Stock | D | −165 164 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Alloy Ventures 2000, LLC | KBIO | Series D Preferred Stock | D | −224 029 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Alloy Ventures 2000, LLC | KBIO | Series C Preferred Stock | D | −181 114 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Alloy Ventures 2000, LLC | KBIO | Series B-2 Preferred Stock | D | −487 489 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Alloy Ventures 2000, LLC | KBIO | Series B-1 Preferred Stock | D | −357 693 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Alloy Ventures 2000, LLC | KBIO | Series A Preferred Stock | D | −194 965 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Alloy Ventures 2000, LLC | KBIO | Common Stock | D | 1 683 817 | 1 691 794 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Series D Preferred Stock | I | −275 539 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Series C Preferred Stock | I | −337 622 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Series B-2 Preferred Stock | I | −1 949 879 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Common Stock | I | 313 527 | 2 632 928 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Common Stock | I | 369 522 | 2 319 401 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Common Stock | I | 1 949 879 | 1 949 879 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Series D Preferred Stock | I | −275 539 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Series C Preferred Stock | I | −337 622 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Series B-2 Preferred Stock | I | −1 949 879 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Common Stock | I | 313 527 | 2 632 928 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Common Stock | I | 369 522 | 2 319 401 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | MPM BIOVENTURES III-QP L.P. | KBIO | Common Stock | I | 1 949 879 | 1 949 879 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series E Preferred Stock | D | −1 207 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series E Preferred Stock | D | −80 731 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series E Preferred Stock | D | −643 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series D Preferred Stock | D | −2 565 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series D Preferred Stock | D | −171 450 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series D Preferred Stock | D | −1 367 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series C Preferred Stock | D | −3 143 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series C Preferred Stock | D | −210 056 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series C Preferred Stock | D | −1 675 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series B-2 Preferred Stock | D | −9 982 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series B-2 Preferred Stock | D | −653 356 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series B-2 Preferred Stock | D | −19 120 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series B-1 Preferred Stock | D | −5 231 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series B-1 Preferred Stock | D | −341 236 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series B-1 Preferred Stock | D | −11 226 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series A Preferred Stock | D | −2 851 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series A Preferred Stock | D | −185 996 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Series A Preferred Stock | D | −6 118 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 1 392 | 31 415 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 93 129 | 2 072 914 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 742 | 43 767 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 2 918 | 30 023 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 195 088 | 1 979 785 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 1 555 | 43 025 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 3 440 | 27 105 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 229 904 | 1 784 697 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 1 833 | 41 470 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 9 982 | 23 665 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 653 356 | 1 554 793 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 19 120 | 39 637 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 5 231 | 13 683 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 341 236 | 901 437 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 11 226 | 20 517 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 2 851 | 8 452 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 185 996 | 560 201 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SOFINNOVA VENTURE PARTNERS V LP | KBIO | Common Stock | D | 6 118 | 9 291 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Smith Brigitte By GBS Genesis | KBIO | Series D Preferred Stock | I | −45 368 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Smith Brigitte By GBS Bioventures II A/C | KBIO | Series D Preferred Stock | I | −170 617 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Smith Brigitte By GBS Genesis | KBIO | Series C Preferred Stock | I | −25 322 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Smith Brigitte By GBS Bioventures II A/C | KBIO | Series C Preferred Stock | I | −59 084 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Smith Brigitte By GBS Genesis | KBIO | Series B-2 Preferred Stock | I | −146 240 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Smith Brigitte By GBS Bioventures II A/C | KBIO | Series B-2 Preferred Stock | I | −341 229 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Smith Brigitte | KBIO | Common Stock | I | 825 613 | 850 613 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | 5AM Partners LLC | KBIO | Series D Preferred Stock | D | −96 612 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | 5AM Partners LLC | KBIO | Series C Preferred Stock | D | −79 886 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | 5AM Partners LLC | KBIO | Series B-2 Preferred Stock | D | −175 488 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | 5AM Partners LLC | KBIO | Series B-1 Preferred Stock | D | −125 185 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | 5AM Partners LLC | KBIO | Common Stock | D | 498 038 | 721 228 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Mitsubishi UFJ Capital II, Limited Partnership | KBIO | Series D Preferred Stock | D | −345 578 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Mitsubishi UFJ Capital II, Limited Partnership | KBIO | Common Stock | D | 393 223 | 393 223 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | GBS Venture Partners Pty, Ltd | KBIO | Series D Preferred Stock | D | −215 985 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | GBS Venture Partners Pty, Ltd | KBIO | Series C Preferred Stock | D | −84 406 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | GBS Venture Partners Pty, Ltd | KBIO | Series B-2 Preferred Stock | D | −487 469 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | GBS Venture Partners Pty, Ltd | KBIO | Common Stock | D | 825 613 | 850 613 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Lehman Brothers Holdings Inc. By LB I Group Inc. | KBIO | Series C Convertible Preferred Stock | I | −974 940 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | Lehman Brothers Holdings Inc. By LB I Group Inc. | KBIO | Common Stock | I | 1 067 059 | 1 067 059 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SINGAPORE BIO INNOVATIONS PTE LTD | KBIO | Series D Preferred Stock | D | −104 387 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SINGAPORE BIO INNOVATIONS PTE LTD | KBIO | Series C Preferred Stock | D | −51 710 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SINGAPORE BIO INNOVATIONS PTE LTD | KBIO | Series B-2 Preferred Stock | D | −175 489 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SINGAPORE BIO INNOVATIONS PTE LTD | KBIO | Series B-1 Preferred Stock | D | −121 149 | 0 | ||||||
| 2013-02-07 | 2013-02-05 | 4 | SINGAPORE BIO INNOVATIONS PTE LTD | KBIO | Common Stock | D | 472 013 | 474 018 | ||||||
| 2013-02-04 | 2013-01-31 | 4 | HEALY JAMES | KBIO | Common Stock | I | 8,0000 | 5 485 | 44 | 5 601 | ||||
| 2013-02-04 | 2013-01-31 | 4 | HEALY JAMES | KBIO | Common Stock | I | 8,0000 | 366 592 | 2 933 | 374 205 | ||||
| 2013-02-04 | 2013-01-31 | 4 | HEALY JAMES | KBIO | Common Stock | I | 8,0000 | 2 923 | 23 | 3 173 | ||||
| 2013-02-04 | 2013-01-31 | 4 | GBS Venture Partners Pty, Ltd | KBIO | Common Stock | D | 8,0000 | 25 000 | 200 | 25 000 | ||||
| 2013-02-04 | 2013-01-31 | 4 | Smith Brigitte By GBS Bioventures II A/C | KBIO | Common Stock | I | 8,0000 | 25 000 | 200 | 25 000 | ||||
| 2013-02-04 | 2013-01-31 | 4 | 5AM Partners LLC | KBIO | Common Stock | D | 8,0000 | 62 500 | 500 | 223 190 | ||||
| 2012-08-13 | 3 | WITHY RAYMOND M | NONE | Common Stock | D | 100 000 | ||||||||
| 2012-08-10 | 3 | Alloy Ventures 2000, L.P. | NONE | Common Stock | D | 28 418 | ||||||||
| 2012-08-10 | 3 | Azan Alain | NONE | Common Stock | I | 414 | ||||||||
| 2012-08-10 | 3 | Azan Alain | NONE | Common Stock | I | 27 116 | ||||||||
| 2012-08-10 | 3 | Azan Alain | NONE | Common Stock | I | 891 | ||||||||
| 2012-08-10 | 3 | Yarranton Geoffrey Thomas | NONE | Common Stock | D | 931 645 | ||||||||
| 2012-08-10 | 3 | Pritchard David | NONE | Common Stock | D | 2 273 521 | ||||||||
| 2012-08-10 | 3 | Shochat Dan | NONE | Common Stock | D | 826 394 | ||||||||
| 2012-08-10 | 3 | 5AM VENTURES LLC | NONE | Common Stock | D | 572 295 | ||||||||
| 2012-08-10 | 3 | EDB Investments Pte Ltd. | NONE | Common Stock | D | 7 142 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
